Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 183
Filtrar
1.
Optom Vis Sci ; 98(3): 258-265, 2021 03 01.
Artículo en Inglés | MEDLINE | ID: mdl-33771955

RESUMEN

SIGNIFICANCE: This study provides insight into the current recommendations, clinical behaviors, and risk assessments of eye care professionals on the topic of rigid contact lens exposure to tap water. This knowledge may motivate professional organizations to develop initiatives to educate eye care professionals on the dangers of contact lens exposure to water. PURPOSE: The purpose of this study was to investigate the practice patterns and risk perceptions of eye care professionals regarding gas-permeable contact lens exposure to tap water. METHODS: A branched-logic survey was started by 320 clinicians, vision scientists, and industry personnel and was fully completed by 272 participants. The survey queried participants about their current practices, recommendations, and perceptions of risk regarding exposure of gas-permeable contact lenses to tap water. RESULTS: Of those who prescribe gas-permeable contact lenses, 57.4% reported rinsing lenses with tap water, whereas only 32.7% reported engaging in this same behavior in front of patients. Of those who reported never rinsing lenses with tap water, 85.6% indicated that rinsing lenses with water increases infection risk, whereas 52.1% of those who rinse lenses with water reported the same perceived risk (P < .001). Of all participants, 60% indicated that wearing contact lenses while showering increases infection risk, and 50.2% of all participants advised patients to avoid this behavior. CONCLUSIONS: A discrepancy exists between perceptions of risk concerning exposure of contact lenses to water and both clinical practices and patient education provided by professionals.


Asunto(s)
Lentes de Contacto/estadística & datos numéricos , Infecciones del Ojo/epidemiología , Conductas Relacionadas con la Salud , Conocimientos, Actitudes y Práctica en Salud , Práctica Profesional/estadística & datos numéricos , Agua/efectos adversos , Soluciones para Lentes de Contacto , Lentes de Contacto/microbiología , Lentes de Contacto/parasitología , Infecciones del Ojo/prevención & control , Femenino , Encuestas Epidemiológicas , Humanos , Masculino , Ajuste de Prótesis
2.
Eur J Ophthalmol ; 31(2): 287-290, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33081522

RESUMEN

Cataract surgery is the most frequently performed elective surgery worldwide. Although considered a safe procedure, potentially sight-threatening adverse events are possible. Among these, post-surgical inflammation and infections are the most relevant. Anti-inflammatory drugs, such as corticosteroids, and topical antibiotics are the pillars for the treatment of inflammation and for the prevention of infections. However, uncertainties remain regarding the duration of both topical antibiotic prophylaxis and corticosteroid treatment. LEADER7, a recent international clinical study conducted with the new fixed combination of levofloxacin and dexamethasone eye drops in patients undergoing uncomplicated cataract surgery, found that 1-week topical antibiotic prophylaxis is just as effective as the 2-week course commonly used in clinical practice. The study also showed that treatment for 1 week with dexamethasone results in complete resolution of inflammatory signs and symptoms in over 85% of patients, for whom further prolongation of corticosteroid treatment is, therefore, not necessary. This new treatment strategy can represent a significant step forward to reduce the unjustified use of prophylactic antibiotics after cataract surgery, limiting the emergence of bacterial resistance, as well as representing an opportunity to optimize the use and safety of the corticosteroid treatment.


Asunto(s)
Endoftalmitis/prevención & control , Infecciones del Ojo/prevención & control , Implantación de Lentes Intraoculares , Facoemulsificación , Complicaciones Posoperatorias , Uveítis/prevención & control , Profilaxis Antibiótica , Dexametasona/uso terapéutico , Endoftalmitis/etiología , Infecciones del Ojo/etiología , Glucocorticoides/uso terapéutico , Humanos , Uveítis/etiología
3.
Optom Vis Sci ; 97(8): 544-548, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32769840

RESUMEN

SIGNIFICANCE: Standardized guidelines that are clinically practical are needed to assist the prescriber in minimizing the risk of conveying infection through multiuse diagnostic contact lens use and reuse.Contact lens prescribers face the specter of transferring potential pathogens from one patient to another when reusing diagnostic (trial) contact lenses on multiple patients because infectious organisms have been recovered from worn contact lenses, although there is no evidence of transmission through this mechanism. These pathogens can be introduced into the system from one patient to another, or they may be introduced by clinician lens handling, storage, or both. These pathogens can cause acute or chronic systemic or ocular infection that can lead to significant morbidity (temporary or permanent) that includes vision loss.


Asunto(s)
Soluciones para Lentes de Contacto/uso terapéutico , Lentes de Contacto Hidrofílicos/normas , Desinfección/métodos , Contaminación de Equipos/prevención & control , Higiene/normas , Prescripciones/normas , Manejo de Especímenes/métodos , Lentes de Contacto Hidrofílicos/microbiología , Transmisión de Enfermedad Infecciosa/prevención & control , Infecciones del Ojo/prevención & control , Desinfección de las Manos , Humanos , Procedimientos de Ortoqueratología
5.
Ann Am Thorac Soc ; 16(8): 957-966, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31091984

RESUMEN

Ophthalmic disease encountered in the intensive care unit (ICU) has a wide spectrum of prevalence and severity. Prolonged exposure of the cornea is common and preventable. Trauma, glaucoma, infection, vascular disease, and burns are among the potential causes of vision loss. Patients are predisposed to ocular complications by the ICU environment and critical illness itself. Critically ill patients require prioritization of life-sustaining interventions, and less emphasis is placed on ophthalmic disease, leading to missed opportunities for vision-saving intervention. It is therefore imperative for intensivists, nurses, and other providers to have an increased awareness and understanding of the broad range of ocular conditions potentially seen in the ICU.


Asunto(s)
Oftalmopatías/etiología , Unidades de Cuidados Intensivos , Oftalmología , Enfermedades de la Córnea/epidemiología , Enfermedades de la Córnea/etiología , Enfermedades de la Córnea/prevención & control , Enfermedad Crítica , Oftalmopatías/epidemiología , Oftalmopatías/prevención & control , Oftalmopatías/terapia , Infecciones del Ojo/epidemiología , Infecciones del Ojo/etiología , Infecciones del Ojo/prevención & control , Humanos , Enfermedad Iatrogénica , Prevalencia , Pronóstico
6.
Nanomedicine (Lond) ; 14(8): 1049-1072, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30901304

RESUMEN

Corneal scarring refers to the loss of normal corneal tissue, replaced by fibrotic tissue (during wound repair) thereby affecting corneal transparency and vision quality. The corneal wound healing process involves a complex series of physiological events resulting in the transformation of transparent keratocytes into opaque myofibroblasts; the prominent cause of irregular extracellular matrix synthesis leading to the development of corneal opacity/hazy vision. Globally, corneal scarring/haze is one of the most prevalent causes of blindness. Ocular trauma (physical and chemical) and microbial infections induce corneal tissue damage. Although great progress has been made in the clinical management of ocular diseases, the global rates of corneal blindness remain high, nonetheless. The topical conventional modalities treating corneal wounds/injuries have inherent limitations/side effects such as low bioavailability of a therapeutic agent, upregulation of the intraocular pressure and the toxicity/allergy of the drug. These limitations/side effects rather than treating the wound, often negatively affect the healing process, especially, when applied frequently for longer periods. Recently, there has been an increasing evidence provided by the preclinical studies that nanotechnology-based drug-delivery systems can improve drug bioavailability, through controlled drug release and targeted delivery. After reviewing the epidemiology, risk factors of corneal scarring/haze and the conventional ocular medicines, we review here the different nanodrug-delivery systems and potential drug candidates including nanoherbal formulations investigated for their efficacy to heal the damaged cornea. Finally, we discuss the challenges of using these nanomedicinal platforms.


Asunto(s)
Cicatriz/metabolismo , Córnea/efectos de los fármacos , Lesiones de la Cornea/tratamiento farmacológico , Miofibroblastos/metabolismo , Cicatrización de Heridas/efectos de los fármacos , Preparaciones de Acción Retardada/química , Composición de Medicamentos/métodos , Sistemas de Liberación de Medicamentos/métodos , Infecciones del Ojo/prevención & control , Humanos , Nanomedicina/métodos , Nanoestructuras/química
7.
Orbit ; 38(1): 43-50, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29874471

RESUMEN

Dog bites result in a diverse range of injuries and complications in the periocular region, particularly in school aged children. It is therefore incumbent on the oculoplastic surgeon to be well versed in both acute and long-term management. The intent of this review is to provide a systematic evaluation of the epidemiology, principles of dog bite wound care, and specific considerations related to common patterns of ophthalmic injury. Review of clinical literature from 1976 to 2014. The majority of periocular injuries result from seemingly benign interactions between young children and familiar dogs. Aggressive saline lavage combined with selective debridement of devitalized tissue is essential. High-risk wounds and vulnerable patient groups may benefit from preventive antibiotic coverage as well as appropriate rabies and tetanus prophylaxis. While the nuances of surgical repair are variable given the heterogeneity of presentation, systematic examination and an algorithm-driven approach underlie the optimal management of these complex injuries.


Asunto(s)
Mordeduras y Picaduras/complicaciones , Perros , Lesiones Oculares/etiología , Traumatismos Faciales/etiología , Animales , Antibacterianos/uso terapéutico , Mordeduras y Picaduras/terapia , Desbridamiento , Infecciones del Ojo/prevención & control , Lesiones Oculares/terapia , Traumatismos Faciales/terapia , Puntaje de Gravedad del Traumatismo , Procedimientos de Cirugía Plástica , Irrigación Terapéutica
8.
Br J Ophthalmol ; 103(10): 1466-1468, 2019 10.
Artículo en Inglés | MEDLINE | ID: mdl-30578245

RESUMEN

OBJECTIVE: To determine postoperative surgical site infection (SSI) rates in three separate patient groups who underwent orbital surgery without prophylactic systemic antibiotics. STUDY DESIGN: Single-centre retrospective descriptive case series. STUDY POPULATION: We studied the notes of 639 consecutive patients who had undergone orbital surgery in our hospital from 2009 through 2013. All patients belonged to either of three groups: (1) clean orbital surgery (n=226); (2) clean orbital surgery with implant (n=290); (3) clean-contaminated surgery (n=92). Thirty-one patients were excluded. RESULTS: Of the total of 608 patients, without systemic antibiotic prophylaxis, only five were diagnosed with SSI 5/608 (0.82%): 1/226 in the 'clean' group, 3/290 in the 'clean-with-implant' group and 1/92 in the 'clean-contaminated' group. All five patients with SSI were effectively treated with antibiotics. CONCLUSION: In this study 'clean', 'clean-with-implant' and 'clean-contaminated' orbital surgery was safely performed without prophylactic antibiotics. Where postoperative infection did occur, the patients were effectively treated with systemic antibiotics. We suggest to restrict the administration of systemic antibiotic prophylaxis in orbital surgery.


Asunto(s)
Profilaxis Antibiótica , Procedimientos Quirúrgicos Oftalmológicos , Enfermedades Orbitales/cirugía , Infección de la Herida Quirúrgica/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Niño , Preescolar , Infecciones del Ojo/prevención & control , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
9.
MMWR Morb Mortal Wkly Rep ; 67(32): 877, 2018 Aug 17.
Artículo en Inglés | MEDLINE | ID: mdl-30114711

RESUMEN

August 20-24, 2018, marks the fifth annual Contact Lens Health Week. In collaboration with partners from clinical, public health, industry, and regulatory sectors, CDC is promoting healthy contact lens wear and care practices to reduce the risk for eye infections among the approximately 45 million persons in the United States who wear contact lenses. Research after outbreaks of rare but serious eye infections in the United States has indicated that these infections occur most often in contact lens wearers who do not take proper care of their contact lenses, indicating a need to promote safer wear and care (1,2).


Asunto(s)
Lentes de Contacto , Brotes de Enfermedades/prevención & control , Infecciones del Ojo/prevención & control , Promoción de la Salud/organización & administración , Aniversarios y Eventos Especiales , Lentes de Contacto/efectos adversos , Infecciones del Ojo/epidemiología , Humanos , Estados Unidos/epidemiología
10.
Cochrane Database Syst Rev ; 7: CD001861, 2018 07 09.
Artículo en Inglés | MEDLINE | ID: mdl-29985545

RESUMEN

BACKGROUND: Recurrent corneal erosion is a common cause of disabling ocular symptoms and predisposes the cornea to infection. It may follow corneal trauma. Measures to prevent the development of recurrent corneal erosion following corneal trauma have not been firmly established. Once recurrent corneal erosion develops, simple medical therapy (standard treatment) may lead to resolution of the episode. However, some people continue to suffer when such therapy fails and repeated episodes of erosion develop. A number of treatment and prophylactic options are then available but there is no agreement as to the best option. This review version is an update to the original version published in 2007 and a previous update published in 2012. OBJECTIVES: To assess the effectiveness and adverse effects of regimens for the prophylaxis of further recurrent corneal erosion episodes, the treatment of recurrent corneal erosion and prophylaxis of the development of recurrent corneal erosion following trauma. SEARCH METHODS: We searched CENTRAL, which contains the Cochrane Eyes and Vision Trials Register; MEDLINE; Embase; LILACS; the ISRCTN registry; ClinicalTrials.gov and the ICTRP. The date of the search was 14 December 2017. SELECTION CRITERIA: We included randomised and quasi-randomised trials that compared a prophylactic or treatment regimen with another prophylaxis/treatment or no prophylaxis/treatment for people with recurrent corneal erosion. DATA COLLECTION AND ANALYSIS: We used standard methods expected by Cochrane. Two authors independently screened search results, extracted data and assessed risk of bias in the included studies using the Cochrane tool for assessing risk of bias. We considered the following outcome measures: resolution of symptoms after treatment; recurrence after complete or partial resolution; symptoms (pain); adverse effects (corneal haze, astigmatism). We graded the certainty of the evidence using GRADE for the three most clinically relevant comparisons. MAIN RESULTS: We included eight randomised and two quasi-randomised controlled trials in the review, encompassing 505 participants. Seven studies were from Europe (Germany, Sweden and the UK), two from East Asia (Hong Kong and Japan) and one from Australia. Nine of the studies examined treatments for episodes of recurrent corneal erosions and one study considered prophylaxis to prevent development of recurrent corneal erosions after injury. Two of the nine treatment studies also enrolled participants in a study of prophylaxis to prevent further episodes of recurrent corneal erosions. The studies were poorly reported; we judged only one study low risk of bias on all domains.Two studies compared therapeutic contact lens with topical lubrication but one of these studies was published over 30 years ago and used a therapeutic contact lens that is no longer in common use. The more recent study was a two-centre UK study with 29 participants. It provided low-certainty evidence on resolution of symptoms after treatment with similar number of participants in both groups experiencing resolution of symptoms at four months (risk ratio (RR) 0.97, 95% confidence interval (CI) 0.62 to 1.53). There was very low-certainty evidence on recurrence after partial or total resolution at seven months' follow-up (RR 1.07, 95% CI 0.07 to 15.54). There was no evidence of an important difference in pain score (score of 3 in the contact lens group and score of 2 in the topical lubrication group, low-certainty evidence) and no adverse effects were reported. The older study, using a contact lens no longer in common use, found an increased risk of pain and complications with the contact lens compared with hypromellose drops and paraffin ointment at night.A single-centre, Australian study, with 33 participants, provided low-certainty evidence of an increased risk of recurrence with phototherapeutic keratectomy compared with alcohol delamination but with wide confidence intervals, compatible with increased or decreased risk (RR 1.27, 95% CI 0.48 to 3.37). Time to recurrence was similar in both groups (6.5 and 6 months, low-certainty evidence). On average people receiving phototherapeutic keratectomy reported less pain but confidence intervals included no difference or greater pain (mean difference (MD) -0.70, 95% CI -2.23 to 0.83, low-certainty evidence). No adverse effects were reported.A 48-participant study in Hong Kong found recurrences were less common in people given diamond burr superficial keratectomy after epithelial debridement compared with sham diamond burr treatment after epithelial debridement (RR 0.07, 95% CI 0.01 to 0.50, moderate-certainty evidence). The study did not report pain scores but adverse effects such as corneal haze (RR 0.92, 95% CI 0.06 to 13.87, low-certainty evidence) and astigmatism (0.88 versus 0.44 dioptres, moderate-certainty evidence) were similar between the groups.A study comparing transepithelial versus subepithelial excimer laser ablation in 100 people found low-certainty evidence of a small increased risk of recurrence of corneal erosion at one-year follow-up in people given the transepithelial compared with subepithelial technique, however, the confidence intervals were wide and compatible with increased or decreased risk (RR 1.20, 95% CI 0.58 to 2.48, low-certainty evidence). Other outcomes were not reported.Other treatment comparisons included in this review were only addressed by studies published two decades or more ago. The results of these studies were inconclusive: excimer laser ablation (after epithelial debridement) versus no excimer laser ablation (after epithelial debridement), epithelial debridement versus anterior stromal puncture, anterior stromal puncture versus therapeutic contact lens, oral oxytetracycline and topical prednisolone (in addition to 'standard therapy') versus oral oxytetracycline (in addition to 'standard therapy') versus 'standard therapy'. AUTHORS' CONCLUSIONS: Well-designed, masked, randomised controlled trials using standardised methods are needed to establish the benefits of new and existing prophylactic and treatment regimes for recurrent corneal erosion. Studies included in this review have been of insufficient size and quality to provide firm evidence to inform the development of management guidelines. International consensus is also needed to progress research efforts towards evaluation of the major effective treatments for recurrent corneal erosions.


Asunto(s)
Enfermedades de la Córnea/prevención & control , Lesiones de la Cornea , Infecciones del Ojo/prevención & control , Antibacterianos/uso terapéutico , Lentes de Contacto , Enfermedades de la Córnea/terapia , Desbridamiento/métodos , Infecciones del Ojo/etiología , Glucocorticoides/uso terapéutico , Humanos , Queratectomía/efectos adversos , Queratectomía/métodos , Gotas Lubricantes para Ojos/administración & dosificación , Dimensión del Dolor , Prednisolona/uso terapéutico , Ensayos Clínicos Controlados Aleatorios como Asunto , Recurrencia , Prevención Secundaria , Tetraciclina/uso terapéutico
11.
Eye Contact Lens ; 44(6): 355-366, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29905583

RESUMEN

OBJECTIVES: This article will examine the current literature, as it relates to contact lens discomfort (CLD) secondary to contact lens solutions. The reader will better understand the characteristics of contact lenses, as they uniquely interact with each type of contact lens solution and also gain a better comprehension of the components of contact lens solution such as preservatives, surfactants, and chelating agents, which may contribute to discomfort. By investigating corneal staining theory and the mechanisms that contribute to its presence, the reader will gain insight into this clinical finding, which relates to selection of contact lens solutions. The FDA standards for testing solutions and how this relates to contact lens keratitis will also be appraised in regards to current ISO recommendations. Finally, better selection of multipurpose contact lens solution (MPS) and hydrogen peroxide-based solutions for patients should be accessible to the clinician based on this review and preexisting clinical findings or diagnoses. METHODS: A review of current published literature from peer reviewed journals and online journals was conducted to gain an understanding of contact lens solution's impact on contact lens discomfort. CONCLUSIONS: Many studies have been conducted comparing comfort between various types of contact lens solutions. It is challenging to decipher this information and apply it clinically when selecting solutions for patients. By comparing solution components, how contact lens solutions interact with different types of lenses, keratitis related to contact lenses, and preexisting ocular conditions, this review will improve a clinician's ability to eliminate CLD.


Asunto(s)
Soluciones para Lentes de Contacto/química , Lentes de Contacto/efectos adversos , Infecciones del Ojo/prevención & control , Dolor Ocular/prevención & control , Queratitis/prevención & control , Soluciones para Lentes de Contacto/efectos adversos , Humanos
12.
Can J Ophthalmol ; 53(3): 252-259, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29784162

RESUMEN

OBJECTIVES: The Goldmann applanation tonometer is the gold standard for measuring intraocular pressure and a possible vector for the transmission of infectious diseases. The purpose of this study is to consolidate the evidence pertaining to the disinfection of Goldmann tonometers in an effort to facilitate an informed discussion regarding public policy in this important area. DESIGN: Systematic review. METHODS: An exhaustive literature review was undertaken to identify primary-level research that assesses the effectiveness of different agents used in the disinfection of Goldmann applanation tonometer prisms. Seven discrete databases were reviewed by 2 independent researchers, and a symmetrical screening process was used to identify and review all pertinent studies. RESULTS: Our review identified only 19 primary-level studies that relate specifically to the disinfection of Goldmann tonometer prisms. These studies are largely heterogeneous with regard to the pathogens and disinfectants that were tested and the experimental protocols that were employed. Accordingly, definitive conclusions as to the optimal agent cannot be made on this basis. Furthermore, the results of our review reinforce previous suggestions that only adenovirus has been transmitted between patients via the Goldmann tonometer. CONCLUSIONS: The present state of the literature does not permit a definitive conclusion regarding optimal disinfection agent for Goldmann applanation tonometer prisms. Further well-constructed studies are required to better delineate the effectiveness of disinfectants in the specific context of tonometer prisms.


Asunto(s)
Desinfección/normas , Infecciones del Ojo/prevención & control , Tonometría Ocular/normas , Humanos , Reproducibilidad de los Resultados
13.
Clin Exp Optom ; 100(4): 341-356, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28597930

RESUMEN

BACKGROUND: This paper provides an updated version of the paper: Infection control guidelines for optometrists 2007. METHODS: Information from peer-reviewed journal articles, guidelines from professional societies, and government health department and other websites and instructions from equipment manufacturers were considered in determining infection risk factors in optometric practice. They were used to revise the recommendations on disinfection, sterilisation and reprocessing procedures for instrumentation and other equipment used in optometric practice as well as personal infection control measures to be undertaken by staff. RESULTS AND CONCLUSIONS: Optometrists and optometric practice staff should adopt measures to minimise the risk of transmission of infection. These include appropriate hand-washing, staff vaccinations, single use instruments/equipment, appropriate disposal of waste, appropriate methods of reprocessing where items are reused, routine employment of standard infection control precautions and application of more rigorous procedures for individuals who are known to be infected or immuno-suppressed. Information provided to patients regarding infection control procedures in topical drug administration, contact lens wear and use of eye make-up are additional considerations for optometrists.


Asunto(s)
Infecciones del Ojo/prevención & control , Control de Infecciones/normas , Optometristas , Optometría/métodos , Guías de Práctica Clínica como Asunto , Humanos
15.
J Fr Ophtalmol ; 40(4): 329-337, 2017 Apr.
Artículo en Francés | MEDLINE | ID: mdl-28365053

RESUMEN

All contact lenses with replacement schedules longer than daily must be maintained. At each step of their use, the lenses may be contaminated. Contact lens solutions perform the essential functions of cleaning, decontaminating and preserving the lenses to prevent infectious problems and improve wearing comfort. Contact lens contamination essentially comes from hands, cleaning solutions, cases, water and the environment. The pathogenic microorganisms are mainly Gram-negative bacteria, fungi and amoebae. Contact lens deposits may or may not have an organic origin. Their presence increases the risk of infection because they serve as a nutrient matrix for microbes, and they are responsible for wearing discomfort. Contact lens solutions differ in their composition, their mechanism of action and the concentration of the various agents. To prescribe the best lens care system to each wearer and for each material, it is necessary to be very familiar with them. Maintenance is the main cause of discomfort with contact lenses, either through improper use, solution-material incompatibility, or a reaction of the wearer to the components.


Asunto(s)
Lentes de Contacto/normas , Higiene , Soluciones para Lentes de Contacto/farmacología , Lentes de Contacto/efectos adversos , Lentes de Contacto/microbiología , Contaminación de Equipos/prevención & control , Seguridad de Equipos/métodos , Seguridad de Equipos/normas , Ojo/inmunología , Ojo/microbiología , Infecciones del Ojo/inmunología , Infecciones del Ojo/prevención & control , Humanos
16.
Medicine (Baltimore) ; 96(5): e5864, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28151861

RESUMEN

To investigate the clinical and microbiological profiles from microbial keratitis following penetrating keratoplasty (PKP) in a tertiary referral center in Taiwan, the medical records of 648 consecutive patients (648 eyes) undergoing PKP between January 2003 and December 2007 were retrospectively reviewed. Patients who subsequently sustained microbial keratitis were enrolled and analyzed for potential risk factors, clinical manifestations, microbiological profiles, complications, graft survival, and final visual outcome. A total number of 42 corneal graft infections (6.5%) were recruited. Mean interval between corneal transplantation and graft infection was 12 ±â€Š9.5 months. Potential risk factors included suture-related problems (31.0%), lid abnormalities (23.8%), persistent epithelial defect (23.8%), contact lens use (14.3%), dry eye (11.9%), and prior rejection episodes (4.8%). Lesions were discovered mostly at the donor-recipient junction ([DRJ] 45.2%). Positive cultures were identified in all of the morbid eyes, of which Pseudomonas aeruginosa was the most common pathogen (38.1%). Despite mandatory hospitalization and topical fortified antibiotics management, complications ensued such as graft failure (71.4%), hypopyon (21.4%), corneal perforation (14.3%), wound dehiscence (11.9%), and endophthalmitis (4.8%). The visual outcome was dismal that graft clarity was achieved in only 12 eyes (28.6%), and that final visual acuity deteriorated to less than 20/200 in 28 eyes (66.7%). In conclusion, microbial keratitis following PKP is a devastating event that severely impairs graft survival rate and postoperative visual outcome which usually occur within the first postoperative year. The incidence of post-PKP microbial keratitis has generally decreased in recent years whilst P. aeroginosa prevails as the leading cause of graft infection in our hospital. Close follow-up by ophthalmologists and elevated self-awareness of patients for at least one year are always encouraged to prevent late-onset infection.


Asunto(s)
Infecciones del Ojo/etiología , Queratitis/etiología , Queratoplastia Penetrante/efectos adversos , Complicaciones Posoperatorias/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/administración & dosificación , Infecciones del Ojo/microbiología , Infecciones del Ojo/prevención & control , Femenino , Supervivencia de Injerto , Humanos , Queratitis/microbiología , Queratitis/prevención & control , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/microbiología , Estudios Retrospectivos , Factores de Riesgo , Taiwán/epidemiología , Centros de Atención Terciaria , Factores de Tiempo , Agudeza Visual , Adulto Joven
19.
Curr Eye Res ; 41(9): 1173-7, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-26766637

RESUMEN

PURPOSE: To evaluate the effects of current hygiene standards for the enucleation of postmortem eyes by investigating the number of microorganisms during subsequent steps of decontamination and tissue processing. MATERIALS AND METHODS: This prospective, non-randomized cohort study includes 184 postmortem eyes of 92 human donors. Enucleation was performed, according to an ophthalmic surgical procedure. Two groups were generated as follows: right eyes were allocated to group A, left eyes were allocated to group B. In group A, a mucosal disinfectant was used accessorily. Conjunctival smears were taken to examine germ load in both groups before any intervention, in group A after mucosal disinfection, in both groups after transportation of the whole globes in transport fluid, and in both groups after a bath in 0.75% povidone iodine solution for at least 3 minutes just before preparation of the corneoscleral disc. Smears were sent to the local microbiologic laboratory in an aseptic package for testing. RESULTS: All smears showed multiple contaminations (n = 184/184 eyes) before treatment with povidone iodine solution. Contamination was in both groups significantly prevented using the treatment strategy of an at least 3-minute bath in 0.75% povidone iodine solution (n = 1/184 eyes; p < 0.01) As a side effect, almost every eye of group A and none of group B showed brown iodine staining corresponding to corneal epithelial erosion. CONCLUSIONS: An aseptic setting for donor enucleation similar to a surgical procedure seems not to influence the outcome of germ colonization. The most effective step to decontaminate donor eyes is to use 0.75% povidone iodine solution for at least 3 minutes.


Asunto(s)
Córnea/efectos de los fármacos , Trasplante de Córnea , Descontaminación/métodos , Bancos de Ojos , Povidona Yodada/farmacología , Donantes de Tejidos , Recolección de Tejidos y Órganos/métodos , Antiinfecciosos Locales/farmacología , Infecciones del Ojo/prevención & control , Estudios de Seguimiento , Humanos , Estudios Prospectivos
20.
Microbes Infect ; 18(4): 254-62, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26706818

RESUMEN

The aim of this study was to determine whether infectious dose of Chlamydia caviae after repeated infections influences the immunological responses and subsequent clearance of pathogen at the ocular surface of guinea pigs. Animals were infected three times via the conjunctiva at six- and twelve-week intervals by applying either 1 × 10(4) or 1 × 10(6) inclusion-forming units (IFUs) of C. caviae. Ocular pathology, infection course, C. caviae-specific serum IgG levels and their capacity to bind and neutralize infection ex vivo were assessed. Animals infected with 1 × 10(4) IFUs had completely diminished ocular infection and pathology after the 2nd infection with increased levels of C. caviae-specific serum IgG and their effective capacity to bind and neutralize C. caviae. Only partial protection was observed in animals infected with 1 × 10(6) IFUs after the 2nd and 3rd infections. Our findings show that full protection was observed in animals repeatedly infected with the lower dose. The lower dose appeared not to compromise the host immune system, thereby enabling fast clearance of the pathogen and the establishment of competent neutralizing antibodies.


Asunto(s)
Infecciones por Chlamydia/inmunología , Infecciones por Chlamydia/microbiología , Chlamydia/inmunología , Chlamydia/patogenicidad , Infecciones del Ojo/inmunología , Infecciones del Ojo/microbiología , Animales , Anticuerpos Antibacterianos/sangre , Anticuerpos Neutralizantes/sangre , Infecciones por Chlamydia/patología , Infecciones por Chlamydia/prevención & control , Modelos Animales de Enfermedad , Infecciones del Ojo/patología , Infecciones del Ojo/prevención & control , Cobayas , Inmunoglobulina G/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...